Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Spiegelman Daniel K
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   155,668    

Indirect Shares

   6,673      
Direct Value   $5,250,478    

Indirect Value

   $0      
Total Shares   162,341      
Total Value   $5,250,478      


CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $1,024,068 CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $1,024,068
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            CV Therapeutics Inc CVTX SVP, CFO 2009-04-09 67,489 2009-04-09 6,673    Premium*  
            Cascadian Therapeutics, Inc CASC Director 2018-03-09 0 2009-12-04 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Financial O... 2019-04-30 47,686 2012-05-29 0    Premium*  
            Relypsa Inc RLYP Director 2016-09-01 0 2015-06-04 0    Premium*  
            Myriad Genetics Inc MYGN Director 2023-06-02 40,493 2020-05-27 0    Premium*  
* Premium Members only  

Records found :    180         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-03-03 4 D $89.57 $214,520 D/D (2,395) 47,293 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2016-06-06 5 OE $0.00 $0 D/D 2,723 11,502 0 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2006-12-12 4 AS $12.92 $38,760 D/D (3,000) 3,439 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2021-06-17 4 AS $30.52 $95,795 D/D (3,139) 23,129 0 %
CASC Cascadian Therapeutics, I... Director   –       •      –    2013-07-10 4 S $1.72 $5,854 D/D (3,403) 20,644 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-03-22 4 D $81.36 $291,513 D/D (3,583) 73,602 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-03-22 4/A D $81.36 $292,733 D/D (3,598) 73,587 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2019-03-22 4 D $88.05 $316,804 D/D (3,598) 61,083 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-05-23 4 AS $87.07 $328,184 D/D (3,769) 58,644 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-05-29 4 D $57.50 $218,040 D/D (3,792) 59,334 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-03-15 4 D $83.57 $318,820 D/D (3,815) 64,705 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-06-01 4 AS $124.16 $489,811 D/D (3,945) 31,679 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-08-01 4 AS $99.33 $397,320 D/D (4,000) 42,944 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2015-06-13 4 D $3.88 $15,563 D/D (4,011) 52,675 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-07-01 4 AS $59.56 $243,063 D/D (4,066) 37,950 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-05-29 4 D $64.46 $269,701 D/D (4,184) 42,016 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-03-15 4 D $92.50 $397,843 D/D (4,301) 16,460 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-05-29 4 D $125.57 $540,579 D/D (4,305) 37,202 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-05-27 4 D $89.09 $383,532 D/D (4,305) 54,339 0 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2009-02-25 4 D $15.58 $67,259 D/D (4,317) 25,510 0 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2007-01-03 4 D $13.81 $60,557 D/D (4,385) 11,786 0 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2007-11-09 4 D $10.12 $45,216 D/D (4,468) 14,020 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2011-06-09 4 A $0.00 $0 D/D 4,538 18,809 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-03-02 4 AS $86.12 $398,120 D/D (4,623) 49,688 0 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2008-02-26 4 OE $6.95 $32,582 D/D 4,688 11,957 0 -
  180  Records found
  1   2   3   4  5   6   7   8      
  Page 4 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us